| | | | | | | | | | |
|
|
| Dockets Entered
On November 2, 2006
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 2001E-0213
|
| Angiomax, Patent Term Extension Application, No. 5,196,404
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
| 2004P-0349
|
| Action on Products containing added Mercury
|
|
|
| 2005D-0490
|
| Guidance for Industry: Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 2)
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| 2006D-0344
|
| Guidance for Industry on Drug Interaction Studies--Study Design, Data Analysis, and Implications for Dosing and Labeling
|
|
|
| 2006D-0383
|
| Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
|
|
|
| 2006N-0107
|
| FDA-Regulated Products Containing Nanotechnology Materials
|
|
|
| 2006N-0292
|
| Unique Device Identification
|
|
|
| 2006N-0352
|
| Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
|
|
|
| 2006N-0430
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; General Licensing Provisions: Biologics License Application, Changes to an Approved Application, Labeling, Revocation an
|
|
|
|
|
|
| 2006N-0431
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Substantial Evidence of Effectiveness of New Animal Drugs
|
|
|
| 2006P-0069
|
| Health Claim Petition: Soluble Fiber from Certain Foods and Coronary Heart Disease
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
| 2006P-0450
|
| Revoke approval of Allergan's supplemental NDA #21-257/S-013 for Lumigan (bimatoprost ophthalmic solution 0.03%) and deny Alcon's supplemental NDA for Travatan (travopr
|
|
|
| 2006V-0447
|
| Laser Light Show
|
|
|
| 2006V-0448
|
| Laser Light Show
|
|
|
| 2006V-0449
|
| Laser Light Show
|
|
|
| 2001E-0213
|
| Angiomax, Patent Term Extension Application, No. 5,196,404
|
|
|
| LET 3
|
| FDA/CDER to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| EMC 732
|
| Mission Possible International
|
| Vol #:
|
| 10
|
|
|
| EMC 733
|
| D. Voetee
|
| Vol #:
|
| 10
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
| NM 1
|
| FDA
|
| Vol #:
|
| 5
|
|
|
| 2004P-0349
|
| Action on Products containing added Mercury
|
|
|
| EC 25
|
| Mrs. Janet Sheehan
|
| Vol #:
|
| 4
|
|
|
| 2005D-0490
|
| Guidance for Industry: Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 2)
|
|
|
| GDL 2
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
| NAD 2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
| | | | | | | | |
|
|
| TS 1
|
| Eastern Research Group Inc
|
| Vol #:
|
| 1
|
|
|
| TS 2
|
| Cook Group Inc
|
| Vol #:
|
| 1
|
|
|
| TS 3
|
| Partners Health Care
|
| Vol #:
|
| 1
|
|
|
| TS 4
|
| DoD
|
| Vol #:
|
| 1
|
|
|
| TS 5
|
| Health Technology Evaluation and Safety
|
| Vol #:
|
| 1
|
|
|
| TS 6
|
| M Piper
|
| Vol #:
|
| 1
|
|
|
| TS 7
|
| Villanova School of Business
|
| Vol #:
|
| 1
|
|
|
| TS 8
|
| Novation
|
| Vol #:
|
| 1
|
|
|
| TS 9
|
| National Electrical Manufacturers Association (NEMA)
|
| Vol #:
|
| 1
|
|
|
| TS 10
|
| Fast Track Technologies Ltd
|
| Vol #:
|
| 1
|
|
|
| TS 11
|
| Dental Trade Alliance
|
| Vol #:
|
| 1
|
|
|
| TS 12
|
| NFD, HCA
|
| Vol #:
|
| 1
|
|
|
| TS 13
|
| Siemens
|
| Vol #:
|
| 1
|
|
|
| 2006N-0352
|
| Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
|
|
|
| EC 154
|
| Victory Center for Health and Healing
|
| Vol #:
|
| 3
|
|
|
| EC 155
|
| dentist
|
| Vol #:
|
| 3
|
|
|
| EC 156
|
| Ms. Desiree Starr DeJesus
|
| Vol #:
|
| 3
|
|
|
| EC 157
|
| UTHSCS Dental School
|
| Vol #:
|
| 3
|
|
|
| EC 158
|
| Mrs. Monica Thomas
|
| Vol #:
|
| 3
|
|
|
| EC 159
|
| Dental Care
|
| Vol #:
|
| 3
|
|
|
| EC 160
|
| Dental Care
|
| Vol #:
|
| 3
|
|
|
| EC 161
|
| Dental Care
|
| Vol #:
|
| 3
|
|
|
| 2006N-0430
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; General Licensing Provisions: Biologics License Application, Changes to an Approved Application, Labeling, Revocation an
|
|
|
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006N-0431
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Substantial Evidence of Effectiveness of New Animal Drugs
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006P-0069
|
| Health Claim Petition: Soluble Fiber from Certain Foods and Coronary Heart Disease
|
|
|
| LET 3
|
| Quaker Oats Company
|
| Vol #:
|
| 1
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
| EC 380
|
| Miss. ANS PERRAULT
|
| Vol #:
|
| 7
|
|
|
| EC 381
|
| Mrs. Arlene Patoray
|
| Vol #:
|
| 7
|
|
|
| EMC 21
|
| National Grocers Association
|
| Vol #:
|
| 3
|
|
|
| 2006P-0450
|
| Revoke approval of Allergan's supplemental NDA #21-257/S-013 for Lumigan (bimatoprost ophthalmic solution 0.03%) and deny Alcon's supplemental NDA for Travatan (travopr
|
|